Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2026

Conditions
Pulmonary NeoplasmAdvanced CancerLocally Advanced Cancer
Interventions
PROCEDURE

Surgery

Participants having been evaluated as operable after receiving first-line treatment (first-line chemotherapy, targeted therapy, immunotherapy, chemotherapy combined with immunotherapy, etc.) will receive surgery.

Trial Locations (1)

021

Ruijin hospital, Shanghai JiaoTong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER